New pill doubles survival in pancreatic cancer
Pancreatic cancer causes a large number of mortalities every year For decades, pancreatic cancer has been one of the deadliest diagnoses. It is often found late, spreads quickly and leaves patients with very few treatment options. Now, a new experimental drug is raising cautious optimism among doctors and patients alike. The drug, called daraxonrasib, is being described by researchers as…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
